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Summary 
We performed a single centre, double blind, randomised, controlled, non-inferiority study 
comparing ultrasound guided fascia iliaca block with spinal morphine for the primary outcome of 
24 h postoperative morphine consumption in patients undergoing primary total hip arthroplasty 
under spinal anaesthesia with levobupivacaine. One hundred and eight patients were 
randomised to receive either ultrasound guided fascia iliaca block (2 mg.kg-1 levobupivacaine) 
(fascia iliaca group) or spinal morphine 100 mcg plus a sham ultrasound guided fascia iliaca 
block using 0.9% saline (spinal morphine group). The pre-defined non-inferiority margin was a 
median difference between the groups of 10 mg in cumulative intravenous morphine use in the 
first 24 h postoperatively. Patients in the fascia iliaca group received 25 mg more intravenous 
morphine than patients in the spinal morphine group (95% CI 9.0-30.5 mg, p < 0.001). 
Ultrasound guided fascia iliaca block was significantly worse than spinal morphine in the 
provision of analgesia after total hip arthroplasty. No increase in side effects was noted in the 
spinal morphine group but the study was not powered to investigate all secondary outcomes.  
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Musculoskeletal disease is the second most common cause of disability globally and is an 
increasing healthcare problem [1,2]. Total hip arthroplasty is an effective surgical procedure 
performed to relieve pain and improve function in patients with disorders such as degenerative 
or inflammatory arthritis. The aim of the anaesthetist is to provide adequate anaesthesia and 
optimal analgesia whilst minimising side effects, and facilitating rapid mobilisation and recovery. 
 
Spinal anaesthesia with opioid is recognised as one of the most effective and widely used 
techniques for providing analgesia for total hip arthroplasty [3]. As morphine is more 
hydrophobic than other opioids, it has a greater degree of rostral spread and a longer duration 
of action [4]. Spinal morphine in combination with systemic morphine is a commonly used 
postoperative regimen for many surgical procedures including total hip arthroplasty [5-7]. The 
use of spinal opioids can be associated with side-effects such as nausea, pruritus, urinary 
retention, sedation, and respiratory depression [8]. Such adverse effects may be uncomfortable 
for the patient, can delay mobilisation and discharge and may, in extreme cases, be life-
threatening [9,10]. Consequently, patients receiving spinal opioids require more intensive 
monitoring postoperatively.  
 
Peripheral nerve blockade has been shown to improve pain scores and reduce morphine 
consumption in patients undergoing total hip arthroplasty [11]. Consensus guidelines for 
postoperative analgesia after total hip arthroplasty confirm that proximal approaches to the 
lumbar plexus (i.e. lumbar plexus blocks) are more effective analgesic techniques than distal 
approaches (i.e. femoral nerve blocks) [3]. However, lumbar plexus blocks may be associated 
with significant complications including spinal and epidural placement, psoas haematoma or 
abscess, retroperitoneal haematoma, renal trauma and systemic local anaesthetic toxicity 
[12,13]. The performance of this technique requires considerable expertise and may be time-
consuming to perform hence limiting its use. The fascia iliaca block provides an indirect 
proximal approach to the lumbar plexus and provides sensory blockade to several of the nerves 
that supply the hip [14,15]. Clinical success rates of this block when performed using traditional 
landmark techniques are variable and have limited its utility [16]. A meta-analysis has 
demonstrated that ultrasound-guided nerve blocks are significantly more successful and last 
around 25% longer than those done using peripheral nerve stimulators [17]. Despite being 
commonly used, there is a lack of evidence relating to the use of the fascia iliaca block for 
analgesia after total hip arthroplasty. One small study examined the use of a modified landmark 
technique and demonstrated reduced morphine consumption when compared with placebo [15]. 
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Using ultrasound to perform fascia iliaca blocks increases success rates compared with the 
landmark technique [18], but until recently the ultrasound-guided technique had not been 
evaluated clinically. One small, single centre study has compared an ultrasound guided fascia 
iliaca block with placebo injection in patients with uncontrolled postoperative pain and showed 
no benefit [19]. There has been no previous comparison of ultrasound-guided fascia iliaca block 
with spinal morphine in patients undergoing total hip arthroplasty. 
 
We hypothesised that there would be no clinically meaningful difference between ultrasound-
guided fascia iliaca block and spinal morphine for a primary outcome measure of 24 h morphine 
consumption in patients undergoing primary elective total hip arthroplasty under spinal 
anaesthesia. If this were the case, then the potential advantages of the ultrasound guided fascia 
iliaca block would be: decreased opioid-related side effects; reduced nursing workload; and 
improved safety profile. A non-inferiority design was used in order to test this hypothesis. 
 
Methods 
We performed a single centre, randomised, controlled, double blind, non-inferiority study. This 
study received approval from the West of Scotland Research Ethics Committee and NHS 
Greater Glasgow and Clyde Research and Development Committee. Written consent was 
obtained from all patients in keeping with the principles of the Declaration of Helsinki. Study 
methodology including power calculations and a priori statistical analysis was published in a 
peer-reviewed journal [20]. 
  
Patients scheduled to undergo primary total hip arthroplasty in a tertiary referral centre for 
orthopaedic and trauma surgery were identified and given a study information sheet. Inclusion 
criteria were: ASA physical status 1-3, 18-85 years of age, weight 50-110 kg, and competence 
to consent. We did not study patients with any of the following conditions: contraindication to 
regional anaesthesia; preference for general anaesthesia; allergy to opioids; neurological 
disorder affecting the lower extremity; significant psychiatric conditions; pregnancy; alcohol or 
drug dependency; or long term intake of World Health Organisation (WHO) step three 
analgesics  
 
Randomisation was achieved using a computer-generated randomisation sequence in permuted 
blocks of four or six patients. The staff member generating the randomisation sequence had no 
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clinical knowledge of the study and was not involved with patient recruitment or data collection. 
Allocation concealment was achieved using opaque, sealed, numbered envelopes. 
  
Patients were randomised to one of two groups. Patients in the fascia iliaca group received 
spinal anaesthesia with 10-15 mg hyperbaric bupivacaine (Marcain Heavy® 0.5%, AstraZeneca, 
London, UK) plus ultrasound-guided fascia iliaca block 2 mg.kg-1 levobupivacaine (Chirocaine®, 
Abbott Laboratories, Chicago, IL, USA) diluted to a total of 40 ml with 0.9% saline. Patients in 
the spinal morphine group received spinal anaesthesia as above with the addition of 100 mcg 
preservative-free spinal morphine (Tayside Pharmaceuticals, Dundee, UK) plus a sham 
ultrasound-guided fascia iliaca block using 0.9% saline. One hundred micrograms of spinal 
morphine has been shown to be an optimal dose in terms of maximising analgesic efficacy 
whilst minimising side-effects [6,7]. 
  
An independent anaesthetist, who had no involvement with study design, data collection or 
analysis, prepared the injectates for the fascia iliaca blocks. This same independent 
anaesthetist prepared and performed the spinal injections and looked after the patient in 
theatre. All spinal injections were performed in a standard manner. The use of sedation with a 
target controlled infusion of propofol and administration of intra-operative fluid was to the 
discretion of the independent anaesthetist. Anti-emetic drugs were not given in theatre unless 
felt to be necessary by this anaesthetist. This anaesthetist was the only person who was aware 
of the group allocation. 
 
A separate study anaesthetist performed the ultrasound-guided fascia iliaca block in a blinded 
fashion using the pre-prepared injectate. The skin was prepared with 2% chlorhexidine 
gluconate in 70% isopropyl alcohol. A 6-14MHz linear ultrasound transducer probe (Sonosite S-
nerve, Bothell, WA, USA) covered in a sterile sheath was placed transversely on the anterior 
thigh below the inguinal ligament. The femoral artery and iliacus muscle were identified and the 
probe moved cranially towards the inguinal crease, proximal to any branching of the femoral 
artery. A 50 mm block needle (Stimuplex, B.Braun Medical Ltd., Sheffield, UK) was visualised to 
penetrate the fascia iliaca lateral to the femoral nerve using an out-of-plane technique, and the 
injection administered incrementally and in a cranial direction after negative aspiration for blood. 
Block efficacy was not assessed prior to the performance of spinal anaesthesia as this would 
have unblinded both patient and operator. The study anaesthetist performing the ultrasound-
 6 
guided fascia iliaca block, as well as the patient, surgeon, ward staff, and research nursing staff 
who collected and recorded the outcome data were all blinded to the study intervention.  
 
Postoperatively, patients were transferred to the recovery area where they were familiarised 
with a patient controlled analgesia (PCA) device (morphine sulphate 1 mg bolus with 5 min 
lockout). Regular analgesia with paracetamol 1g every 6 h was prescribed and the patients’ 
usual medications (including non-steroidal anti-inflammatory drugs) were continued. After 24 h, 
the PCA was discontinued and oral morphine used as required. 
 
The primary outcome measure was 24 h postoperative morphine consumption as self-
administered using a PCA. Secondary outcomes included: time to first morphine administration; 
morphine consumption at 3 h, 6 h, 12 h, 36 h and 48 h; pain scores at 3 h, 6 h, 12 h, 24 h, 36 h 
and 48 h at rest and on movement (as measured by an 11-point numeric rating score pain score 
where 0 is no pain and 10 the worse pain imaginable); episodes of respiratory depression; 
hypotension; postoperative nausea and vomiting (nausea score of ≥2 where 0 = none, 1 = mild, 
2 = moderate, 3 = severe nausea and 4 = patient vomiting); pruritus; sedation (sedation score of 
≥ 2 where 0 = awake, S = normal sleep, 1 = drowsy but easy to rouse, 2 = sedated and difficult 
to rouse, and 3 = unconscious); administration of naloxone; urinary retention requiring 
catheterisation; quadriceps strength pre-mobilisation (Medical Research Council power grade 0-
4); time to first mobilisation (as defined by patient able to mobilise from bed to chair); and 
patient satisfaction at 48 h using a visual analogue scale (0–100 mm, where 0 is absolutely not 
satisfied and 100 is completely satisfied). These data were recorded by ward staff and collated 
by research nursing staff who were blinded to group assignment. Data relating to demographics, 
performance of fascia iliaca block and spinal injections, use of paracetamol pre-operatively, 
length of surgery, and surgical blood loss were also collected.  
 
In order to calculate sample size, we used a method suggested for non-inferiority trials [21,22]. 
Type 1 error (α) was set at 0·05 and type 2 error (β) at 0·8. We considered a difference between 
groups (δ) of greater than 10 mg of morphine to be clinically significant as this equates to one 
subcutaneous dose of morphine, which is commonly used in postoperative analgesia pain 
protocols [23]. Including allowance for an attrition rate of 10%, we planned to recruit 108 
patients.  
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Statistical analyses were performed using RStudio (version 0·98·953, RStudio Inc., Boston MA, 
USA). Both intention to treat and ‘as treated’ analyses were performed. Data were assessed for 
normality using the Shapiro test. The primary outcome measure was assessed using the 
difference in median values and confidence intervals between the two groups as is 
recommended for non-inferiority studies [21]. We planned to declare non-inferiority of the fascia 
iliaca group with respect to the spinal morphine group if the upper boundary of the two-sided 
95% confidence interval of the difference in median 24 h morphine consumption between 
groups was <10 mg. Because of the right-skewed distribution of median 24 h morphine 
consumption, confidence interval construction was done without distribution assumptions by 
using a bias-corrected bootstrapping technique with 10,000 replications [24,25]. Descriptive 
statistics were calculated for demographic variables. Z tests of two proportions were used for 
simple count data, Student’s t tests for normally distributed demographic variables and Wilcoxon 
rank sum tests for non-parametric data. Statistical tests were two sided and a p value of <0·05 
was considered statistically significant. There was no data monitoring committee appointed to 
oversee this study but any serious adverse events were reported to the West of Scotland 
Research Ethics Committee and NHS Greater Glasgow and Clyde Research and Development 
Committee for review. 
 
Results 
 
From 23rd May 2011 to 7th April 2014, 108 patients were recruited and randomised to either of 
the two study groups (Fig. 1).  Two patients did not undergo study intervention and subsequent 
surgery. The first had cellulitis near the operative site and was postponed by the operating 
surgeon, and the second was postponed due to lack of time on the operating list. Both of these 
patients were withdrawn from the ‘as treated’ analysis. Two patients required general 
anaesthesia due to failure of spinal insertion (fascia iliaca group) and failure of spinal block 
(spinal morphine group). One patient required general anaesthesia due to the development of 
jerking movements, for which no sinister cause could be found, whilst being sedated with 
propofol (fascia iliaca group). These patients were withdrawn from the study as directed by the 
study protocol [20]. One-hundred and eight patients were analysed in the intention to treat 
analysis and 103 in the ‘as treated’ analysis.  
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Figure 1. CONSORT flow diagram of patients undergoing total hip arthroplasty and randomised 
to fascia iliaca or spinal morphine groups. 
 
 
 
There were no significant differences in demographics, duration of surgery or blood loss 
between study groups (Table 1).  
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In the ‘as treated’ analysis, the difference between median (95% CI) 24 h morphine 
consumption of the two groups was 25 (9.0-30.5) mg. The intention to treat analysis yielded a 
similar difference between median (95% CI) morphine consumption of 24 (14-29) mg (Fig. 2). 
The intention to treat analysis therefore shows inferiority of ultrasound guided fascia iliaca block 
with respect to spinal morphine as the 95% CI lies completely outside the non-inferiority bounds. 
The 'as treated' analysis includes fewer subjects and therefore has less power to show 
inferiority. However, it still shows that ultrasound guided fascia iliaca block is significantly worse 
than spinal morphine. 
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Figure 2. Cumulative postoperative 24 h morphine consumption in fascia iliaca and spinal 
morphine groups, shown as intention to treat and ‘as treated’ analyses. Values are median with 
error bars indicating two-sided 95% confidence intervals. The zone of non-inferiority is 
represented by the dashed line and was set a priori at < 10 mg of morphine. 
 
 
All predefined secondary outcomes which reached statistical significance (p < 0.05) favoured 
spinal morphine (Tables 2-4). There were no statistically significant differences between the 
groups for the remaining secondary outcomes; however, the study was not powered for these 
outcomes. 
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Table 2. Cumulative morphine consumption at different time points in patients undergoing total 
hip arthroplasty and randomised to fascia iliaca and spinal morphine Groups. Values are 
median (IQR [range]). * includes intravenous equivalent of oral morphine administered. 
 Fascia iliaca group 
(n = 52) 
Spinal morphine group 
(n = 51) 
p value 
Time to first morphine 
requirement; min  
130·5 (60-240 [5-1170]) 129 (55-228 [5-1830]) 0.930 
Cumulative i.v. morphine 
consumption at 3 h; mg 
3 (0-11 [0-25]) 1 (0-3 [0-12]) 0.007 
Cumulative i.v. morphine 
consumption at 6 h; mg 
13.5 (5.75-20.75 [0-44]) 4 (2-9 [0-38]) < 0.001 
Cumulative i.v. morphine 
consumption at 12 h; mg 
24 (14-35·5 [0-75]) 10 (2.5-22·5 [0-65]) < 0.001 
Cumulative i.v. morphine 
consumption at 24 h; mg 
39 (18-49·5 [0-138]) 14 (4.5-32·5 [0-105]) < 0.001 
Cumulative i.v. morphine 
consumption at 36 h; mg 
39.5 (18-55 [0-143]) 15 (5-32.5 [0-105]) < 0.001 
Cumulative morphine 
consumption at 48 h*; mg 
42.3 (20.25-55.08 [0-163] 19 (11-38.67 [0-105]) 0.003 
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Table 3. Postoperative pain scores at rest and on movement as measured by Numeric Rating 
Score (NRS) in patients undergoing total hip arthroplasty and randomised to fascia iliaca and 
spinal morphine Groups. Values are median (IQR [range]). 
 Fascia iliaca group 
(n = 52) 
Spinal morphine group 
(n = 51) 
p value 
NRS 3 h at rest  0 (0-4 [0-9]) 0 (0-1 [0-7]) 0.151 
NRS 6 h at rest 3 (0-5 [0-10]) 0 (0-2 [0-7]) <0.001 
NRS 12 h at rest  2 (0-3 [0-9]) 0 (0-2 [0-7]) 0.004 
NRS 24 h at rest 0.5 (0-3.75 [0-8]) 0 (0-4 [0-10]) 0.828 
NRS 36 h at rest 0 (0-4.75 [0-10]) 0 (0-1 [0-7]) 0.519 
NRS 48 h at rest 1 (0-2 [0-7]) 1 (0-4 [0-7]) 0.265 
NRS 3 h on movement 0 (0-4 [0-10]) 0 (0-2 [0-10]) 0.950 
NRS 6 h on movement  3 (0-5.25 [0-10]) 0 (0-3.5 [0-10]) 0.026 
NRS 12 h on movement 2 (0-4 [0-10]) 0 (0-2 [0-10]) 0.032 
NRS 24 h on movement 2 (0-4 [0-10]) 2 (0-6 [0-10]) 0·511 
NRS 36 h on movement  0 (0-4 [0-10]) 0 (0-2.5 [0-10]) 0.674 
NRS 48 h on movement 4 (2-6 [0-10]) 4 (3-7 [0-10]) 0.579 
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Table 4 – Secondary outcomes measures for patients undergoing total hip arthroplasty and 
randomised to fascia iliaca and spinal morphine groups. Values are number or median (IQR 
[range]).  
 Fascia iliaca group 
(n = 52) 
Spinal morphine group  
(n = 51) 
p value 
Respiratory depression < 8 
breaths min-1 
0  0  - 
Systolic blood pressure < 80 
mmHg  
6 1 0.124 
Systolic blood pressure 
decrease > 25% from baseline 
29 25 0.625 
Urinary catheterisation 15 20 0.367 
PONV score >2 9 7 0.818 
Anti-emetic administration 24 25 0.925 
Pruritus requiring treatment  1 2 0.986 
Pruritus considered to be 
distressing  
3 6 0.466 
Sedation score > 2  1 0 1.000 
Time to mobilisation; h  25 (20-42 [3-66]) 23 (19-25.5 [4-48]) 0.039 
Mobile at first attempt  38 44 0.156 
Quadriceps strength prior to 
mobilisation; MRC grade 
4 (4-5 [0-5]) 4 (4-5 [3-5]) 0.063 
Patient satisfaction at 48 h 
measured by VAS; mm 
80 (50-89 [21-100]) 76 (59-89 [0-100]) 0.57 
PONV, postoperative nausea and vomiting; MRC, Medical Research Council; VAS, visual 
analogue scale. 
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There were six serious adverse events which are shown in Table 5. There were no statistically 
significant differences in the number of adverse or serious adverse events between the groups. 
Each of these incidents was reported according to local research governance protocols. Only 
serious adverse event number five is potentially related to the study intervention and was not 
permanent. All patients were followed up by the surgical team. 
 
Table 5. Serious adverse events occurring in patients undergoing total hip arthroplasty and 
randomised to fascia iliaca and spinal morphine groups. 
Nature of serious adverse event Study Group 
Pulmonary embolism  Spinal morphine 
Pulmonary embolism Fascia iliaca 
Multiple pulmonary emboli  Fascia iliaca 
Wound infection resulting in multi-organ failure Spinal morphine 
Femoral nerve palsy (resolved completely within 3 months)  Fascia iliaca 
Late wound infection, hyponatraemia and confusion Fascia iliaca 
 
 
Discussion 
This randomised, controlled, double blind, non-inferiority study, showed that ultrasound-guided 
fascia iliaca block is inferior to spinal morphine in the provision of analgesia after total hip 
arthroplasty and does not confer any advantage in terms of side-effect profile. This is the first 
study to compare spinal morphine with ultrasound-guided fascia iliaca block for total hip 
arthroplasty. This study adds useful information to what is already known about the provision of 
anaesthesia for total hip arthroplasty and is consistent with other evidence that confirms lumbar 
plexus block as being inferior to spinal morphine for these patients [5,26]. 
  
A non-inferiority study has a number of advantages over a traditional superiority study [21]. In 
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particular, a non-inferiority design is useful to compare two interventions whereas a superiority 
study is useful in comparing an intervention with placebo. The most important consideration in a 
non-inferiority study is the magnitude of the non-inferiority margin (). This should be the 
smallest difference that would be clinically important and the magnitude of the non-inferiority 
margin should therefore be smaller than differences between groups that are used in superiority 
study design. As the non-inferiority margin is so important it should be specified prior to 
commencement of the study, otherwise non-inferiority may be demonstrated by increasing the 
non-inferiority margin. In this trial we used a non-inferiority margin of 10mg morphine, the 
equivalent to a single subcutaneous dose. A further advantage of an adequately powered non-
inferiority study is that there is no possibility of a “negative” trial; the possible outcomes are non-
inferior, inferior, superior or uncertain. This means that if a new treatment is shown to be non-
inferior, this allows the newer intervention to be evaluated on the basis of other considerations 
such as side effects or cost. In the reporting of a non-inferiority study, it is recommended that 
both intention to treat and ‘as treated’ analyses are reported. There is greater confidence in the 
validity of the results when both analyses give consistent results [21]. Both intention to treat and 
‘as treated’ analyses are consistent, in that the value for the median difference in morphine 
consumption is to the right of the non-inferiority margin. From these data, we do not recommend 
replacing spinal morphine with ultrasound-guided fascia iliaca block. 
 
These findings can be explained by the innervation of the hip joint. Even if a fascia iliaca block 
was entirely successful in anaesthetising the lateral cutaneous nerve of thigh, femoral and 
obturator nerves, it would not provide complete anaesthesia and hence analgesia of the hip, 
due to the innervation received from the sacral plexus as well as a variable supply from the 
ilioinguinal, iliohypogastric and genitofemoral nerves. A limitation of our study relates to the fact 
that fascia iliaca block efficacy was not assessed prior to administering the spinal anaesthetic. 
This could have resulted in patients in the fascia iliaca group having higher analgesic 
requirements due to inadequacy of the block. There were several reasons for not checking 
block efficacy. The routine method for checking block efficacy is assessing sensation in the 
distribution of the lateral cutaneous nerve of thigh and the femoral nerve, and motor power in 
the distribution of the obturator nerve. This, however, is time consuming and not representative 
of usual clinical practice. Furthermore, any assessment of the efficacy of the block could have 
unblinded both the patient and the anaesthetist performing the block. 
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The morphine consumption seen in both groups was in keeping with that seen in other studies. 
In a spinal morphine dose finding study, patients undergoing total hip arthroplasty who received 
spinal anaesthesia with no spinal opioid required around 75 mg of intravenous morphine in the 
first 24 h postoperatively [27]. This is significantly more than was required by patients receiving 
the ultrasound-guided fascia iliaca block in our study indicating that these patients did receive 
some analgesia benefit from the block. In other studies examining femoral and “3 in 1” nerve 
blocks for total hip arthroplasty, 24 h postoperative consumption of intravenous morphine (or its 
equivalent when other opioids were used) ranged from 7-60 mg [28-32]. However, these studies 
were highly heterogeneous making direct comparison difficult. In other studies in which 0·1mg 
of spinal morphine was administered to patients undergoing total hip arthroplasty, mean 
intravenous 24 h morphine consumption was reported to be 10-30 mg [6,27]. The median 24 h 
morphine consumption of 14 mg in the spinal morphine group in our study would, therefore, be 
in keeping with this range. 
 
The use of the fascia iliaca block for analgesia after total hip arthroplasty has been investigated 
in two other studies. The first found that a fascia iliaca block performed using a modified 
landmark technique reduced 24 h morphine consumption when compared with placebo [15]. 
Direct comparison with our study is complicated, however, by the addition of clonidine to the 
fascia iliaca block. This could have influenced analgesic requirements as clonidine has 
analgesic as well as sedating effects even when administered perineurally [33]. A second, more 
recent study, compared the postoperative performance of ultrasound-guided fascia iliaca block 
with placebo in patients who had undergone total hip arthroplasty and had a numeric rating pain 
score of > 3 in the post-anaesthesia care unit. The group of patients receiving fascia iliaca block 
had neither improved postoperative pain scores nor reduced morphine consumption [19]. This is 
in keeping with our findings.  
 
Pain scores in our study were generally low, and whilst statistically significantly different at some 
points, this is arguably unlikely to have resulted in a clinically significant difference. This is likely 
to be due to the fact that all patients had the ability to titrate their analgesia to effect using the 
PCA device. The greatest difference in morphine consumption was seen between 6 and 12 h 
when the analgesic effect of the fascia iliaca blocks may have been wearing off. Whilst the use 
of ultrasound guidance has been shown to increase the duration of nerve blockade [17], our 
data suggest that any analgesic effect of the fascia iliaca blocks was diminishing prior to the 
offset of analgesia from the spinal morphine. Morphine consumption between 24 and 48 h was 
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comparably low in each group indicating that the first 24 h is the most painful period 
postoperatively. Reassuringly, there were no episodes of respiratory depression in either group. 
Side effects commonly attributed to spinal morphine such as urinary retention, pruritus, 
sedation, nausea, and hypotension were no different between groups. However, it should be 
noted that this study was not powered for the secondary outcomes. 
 
The use of sham blocks in randomised controlled trials remains controversial [34]. We 
considered the use of a sham block in this study to have scientific merit as there was no other 
way of ensuring that the study was truly double blind. The risk to the patient from an ultrasound-
guided fascia iliaca block with saline is recognised to be lower than other regional techniques 
due to the fact that the needle is not directed toward the femoral nerve or artery; indeed national 
bodies have agreed that due to this lower risk, the fascia iliaca block can be performed by non-
physicians [35]. We accept that the fascia iliaca block is not without risk and patients were 
informed and consent obtained for the possibility that they may receive a sham nerve block.  
 
Total hip arthroplasty is one of the commonest procedures performed in the UK. The patients in 
this study are similar in terms of weight, and physical status (ASA grade) of the patients 
reported in the UK National Joint Registry [36]. It is, therefore, reasonable to consider that the 
results of this study are relevant to UK practice. This single centre, randomised, double blind, 
non-inferiority study has shown that ultrasound-guided fascia iliaca block is not only significantly 
worse in the provision of analgesia after total hip arthroplasty but confers no advantage in 
reducing the side-effect profile. The effects of an ultrasound-guided fascia iliaca block 
administered in addition to spinal morphine, or the use of a fascia iliaca continuous infusion 
were not investigated in this study but would be of interest as these may have a morphine-
sparing effect in the postoperative period.  
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